Clinical Trials Logo
  1. Home
  2. Metabolic Disorders
  3. NCT02311270
  4. Details
NCT02311270 Clinical Trial

Survey on Cardiovascular Events in Patients With Metabolic Disease on Chronic Carnitine Supplementation

Metabolic Disorders Clinical Trial

Official title:
Survey on Cardiovascular Events in Patients With Metabolic Disease on Chronic Carnitine Supplementation

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT02311270
Other study ID # NAMDC7412
Secondary ID
Status Completed
Phase N/A
First received September 12, 2014
Last updated September 22, 2016
Start date September 2014
Est. completion date June 2016

Study information
Verified date September 2016
Source University of South Florida
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Observational [Patient Registry]

Clinical Trial Summary

The purpose of this study is to learn about the effects of long term carnitine use in patients with metabolic disorders and its potential relationship to cardiovascular events.

Description:

This online cross-sectional survey will examine the self-reported long-term carnitine use in patients with metabolic disorders and any potential relationship to cardiovascular events.

Recruitment information / eligibility
Status Completed
Enrollment 106
Est. completion date June 2016
Est. primary completion date September 2015
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group N/A and older
Eligibility Inclusion Criteria:

- Diagnosis of mitochondrial disease or any other metabolic disorder

- Any age group

- NAMDC or RDCRN registry participant

Exclusion Criteria:

- Inability to provide informed consent and complete survey

- Lack of participation in NAMDC or RDCRN registry

Study Design

Observational Model: Cohort, Time Perspective: Cross-Sectional

Related Conditions & MeSH terms

Locations
Country Name City State
United States University of South Florida Tampa Florida

Sponsors (2)
Lead Sponsor Collaborator
University of South Florida National Institutes of Health (NIH)

Country where clinical trial is conducted

United States, 

Outcome
Type Measure Description Time frame Safety issue
Primary Assess how many patients with metabolic disorders are on chronic carnitine supplementation. Up to one year from study activation. No
Secondary Assess how many patients who are on chronic carnitine supplementation have experienced a cardiovascular event. Up to one year from study activation No
See also
  Status Clinical Trial Phase
Completed NCT02039596 - Nutritional Metabolomics: the Search for Dietary Exposure Variables N/A
Completed NCT04142424 - A Study to Understand the Safety, Tolerability, and Activity of Drug in Body Over a Period of Time of AZD2693, in Subjects of Non-Childbearing Potential in Overweight But Otherwise Healthy Subjects, and Healthy Chinese and Japanese Subjects Phase 1
Recruiting NCT05398783 - A Natural History Study of Metabolic Sizing in Health and Disease
Completed NCT00387166 - Socioeconomic Status, Psychosocial Factors, and CVD Risk in Mexican-American Women N/A
Not yet recruiting NCT06358118 - Buyuan-zhixiao Formula in the Treatment of Elderly Patients With Diabetes and Multiple Metabolic Disorders N/A
Completed NCT02130908 - A Study on the Possible Health Effects of Lean Fish, Fatty Fish and Lean Meat Intake in Non-obese Adults N/A
Recruiting NCT03128996 - Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders Phase 1/Phase 2
Terminated NCT02354443 - A Trial of a Single ProHema-CB Product Transplant in Pediatric Patients With Inherited Metabolic Disorders Phase 1
Recruiting NCT02503384 - Clinical and Basic Study for Pediatric Liver Transplantation N/A
Active, not recruiting NCT01894139 - An Optimized Programming of Healthy Children (APPROACH) N/A
Completed NCT04868240 - Concurrent Training and Metabolic Profile, Lung Function, Quality of Life and Stress N/A
Terminated NCT02231710 - Safety Study of Gene Modified Donor T Cell Infusion After Stem Cell Transplant for Non-Malignant Diseases Phase 1
Recruiting NCT00920972 - Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant Diseases Phase 1/Phase 2
Active, not recruiting NCT03188107 - Interrater Reliability of Infant Motor Profile N/A
Withdrawn NCT03284658 - Biomarker for the Early Diagnosis and Monitoring in Tyrosinemia Type 1 (BioTyrosin)
Completed NCT06067126 - Post-delivery Maternal-offspring Obesity and Metabolic Risk After a Prepregnancy Weight-loss Intervention
Completed NCT02107872 - Study to Assess the Safety and Tolerability of Multiple Ascending Doses of REGN1500 Phase 1
Recruiting NCT02419898 - Oxfordshire Women and Their Children's Health
Terminated NCT01343680 - Trial of Two Central Venous Catheter (CVC) Flushing Schemes in Pediatric Hematology and Oncology Patients Phase 3

External Links